Insmed (INSM) Long-Term Debt Repayments (2010)

Insmed (INSM) posted quarterly Long-Term Debt Repayments of $461000.0 for Q4 2010.

Insmed (INSM) Long-Term Debt Repayments (2010) Analysis & Trends

Insmed's Long-Term Debt Repayments history runs 1 years deep, the most recent figure standing at $461000.0 for Q4 2010.

In Q4 2010, Long-Term Debt Repayments changed N/A year-over-year to $461000.0; the TTM figure through Sep 2020 stood at $461000.0 (changed N/A YoY), while the FY2025 annual figure was $2.0 million, changed N/A from the prior year.
Long-Term Debt Repayments for Q4 2010 stood at $461000.0.
The five-year high for Long-Term Debt Repayments was $461000.0 in Q4 2010, with the low at $461000.0 in Q4 2010.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Repayments (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	17.05 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Roivant Sciences	26.16 Bn	26.85 Bn	1.16 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2010	461,000.00
Dec 31, 2010	461,000.00